Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Meandering ocular toxocariasis.

E M Sorr

    Retina (Philadelphia, Pa.)
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Ocular toxocariasis, caused by the Toxocara canis worm, presents a new migratory pattern within the retina. This case highlights periodic intraretinal movement and encapsulation, with photocoagulation as the recommended treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Subretinal neovascularization in children and adolescents.

    Journal of pediatric ophthalmology and strabismus·1995
    Same author

    Pasteurella multocida endophthalmitis.

    The British journal of ophthalmology·1987
    Same author

    Photocoagulation of subretinal neovascularization associated with choroidal osteoma.

    Archives of ophthalmology (Chicago, Ill. : 1960)·1987
    Same author

    Rubella subretinal neovascularization.

    Transactions - Pennsylvania Academy of Ophthalmology and Otolaryngology·1986
    Same author

    Management of giant retinal tears without scleral buckling.

    Retina (Philadelphia, Pa.)·1986
    Same author

    Retinal pigment epithelial tears.

    Ophthalmology·1983
    Same journal

    Persistent placoid maculopathy: long term outcomes and prognostic factors.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    ANTI-VEGF THERAPY SWITCHING RETINAL DISEASES: Characterizing Clinical Manifestations and Common Involved Genes: ERRATUM.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    THE EFFICACY AND SAFETY OF SUBRETINAL BALANCED SALT SOLUTION INJECTION IN DIABETIC MACULAR EDEMA WITH HARD EXUDATES: ERRATUM.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    AMNIOTIC MEMBRANE COVERAGE COMBINED WITH EARLY VITRECTOMY IN THE MANAGEMENT OF PERFORATING GLOBE INJURIES: A NOVEL SURGICAL TECHNIQUE.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    Mid-Phase Hyperfluorescent Plaques as a biomarker of disease activity in Central Serous Chorioretinopathy: Clinical Course and Treatment Response - MICRoN report number Ten.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    Severe retinal non-perfusion is associated with fewer retinal lesions on ultra-wide field fundus photography in proliferative diabetic retinopathy.

    Retina (Philadelphia, Pa.)·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Infectious Diseases
    • Parasitology

    Background:

    • Ocular toxocariasis, a parasitic eye infection, typically manifests as peripheral inflammatory masses, posterior pole granulomas, or endophthalmitis.
    • Understanding the diverse clinical presentations of ocular toxocariasis is crucial for accurate diagnosis and management.

    Observation:

    • This report details a novel presentation of ocular toxocariasis involving periodic intraretinal larval migration.
    • The observed pattern included phases of movement, quiescence with encapsulation, reemergence, and subsequent migration within the retina.

    Findings:

    • Serologic confirmation using ELISA identified Toxocara canis as the causative agent.
    • The migratory behavior observed in this human case mirrors that of the Toxocara canis larva in animal models.

    Related Experiment Videos

    Implications:

    • This case expands the spectrum of recognized ocular toxocariasis presentations.
    • Photocoagulation is identified as the primary treatment modality for this specific intraretinal migratory form.